|
1.
|
Gelenberg AJ, Dunner DL, Rothschild AJ, Pedersen R, Dorries KM, Ninan PT. Sexual Functioning in Patients With Recurrent Major Depressive Disorder Enrolled in the PREVENT Study. J Nerv Ment Dis. 2013 Apr; 201(4):266-73.
|
|
|
|
|
2.
|
Freeman MP, Gelenberg AJ. Magnanimity. J Clin Psychiatry. 2013 Jan; 74(1):6-9.
|
|
|
|
|
3.
|
Thota AB, Sipe TA, Byard GJ, Zometa CS, Hahn RA, McKnight-Eily LR, Chapman DP, Abraido-Lanza AF, Pearson JL, Anderson CW, Gelenberg AJ, Hennessy KD, Duffy FF, Vernon-Smiley ME, Nease DE, Williams SP. Collaborative care to improve the management of depressive disorders: a community guide systematic review and meta-analysis. Am J Prev Med. 2012 May; 42(5):525-38.
|
|
|
|
|
4.
|
Torrente MP, Gelenberg AJ, Vrana KE. Boosting serotonin in the brain: is it time to revamp the treatment of depression? J Psychopharmacol. 2012 May; 26(5):629-35.
|
|
|
|
|
5.
|
Gelenberg AJ. Editor's note. J Clin Psychiatry. 2011 Mar; 72(3):414.
|
|
|
|
|
6.
|
Thase ME, Gelenberg A, Kornstein SG, Kocsis JH, Trivedi MH, Ninan P, Li T, Pedersen R, Keller M. Comparing venlafaxine extended release and fluoxetine for preventing the recurrence of major depression: results from the PREVENT study. J Psychiatr Res. 2011 Mar; 45(3):412-20.
|
|
|
|
|
7.
|
Gelenberg AJ. Optimizing depression treatment to increase the likelihood of remission. J Clin Psychiatry. 2010 Sep; 71(9):e22.
|
|
|
|
|
8.
|
Gelenberg AJ, Thase ME. Performance improvement CME: improving outcomes in depression. J Clin Psychiatry. 2010 Aug; 71(8):e19.
|
|
|
|
|
9.
|
Gelenberg AJ. A review of the current guidelines for depression treatment. J Clin Psychiatry. 2010 Jul; 71(7):e15.
|
|
|
|
|
10.
|
Gelenberg AJ. NCDEU's golden anniversary. J Clin Psychiatry. 2010 Jul; 71(7):820.
|
|
|
|
|
11.
|
Mundt JC, Greist JH, Gelenberg AJ, Katzelnick DJ, Jefferson JW, Modell JG. Feasibility and validation of a computer-automated Columbia-Suicide Severity Rating Scale using interactive voice response technology. J Psychiatr Res. 2010 Dec; 44(16):1224-8.
|
|
|
|
|
12.
|
Gelenberg AJ. Complementary and alternative medicine in psychiatry. J Clin Psychiatry. 2010 Jun; 71(6):667-8.
|
|
|
|
|
13.
|
Trivedi MH, Dunner DL, Kornstein SG, Thase ME, Zajecka JM, Rothschild AJ, Friedman ES, Shelton RC, Keller MB, Kocsis JH, Gelenberg A. Psychosocial outcomes in patients with recurrent major depressive disorder during 2 years of maintenance treatment with venlafaxine extended release. J Affect Disord. 2010 Nov; 126(3):420-9.
|
|
|
|
|
14.
|
Gelenberg AJ. The prevalence and impact of depression. J Clin Psychiatry. 2010 Mar; 71(3):e06.
|
|
|
|
|
15.
|
Gelenberg AJ. Using assessment tools to screen for, diagnose, and treat major depressive disorder in clinical practice. J Clin Psychiatry. 2010; 71 Suppl E1:e01.
|
|
|
|
|
16.
|
Nutt DJ, Davidson JR, Gelenberg AJ, Higuchi T, Kanba S, Karamustafalioglu O, Papakostas GI, Sakamoto K, Terao T, Zhang M. International consensus statement on major depressive disorder. J Clin Psychiatry. 2010; 71 Suppl E1:e08.
|
|
|
|
|
17.
|
Gelenberg AJ. Depression symptomatology and neurobiology. J Clin Psychiatry. 2010 Jan; 71(1):e02.
|
|
|
|
|
18.
|
Kocsis JH, Gelenberg AJ, Rothbaum BO, Klein DN, Trivedi MH, Manber R, Keller MB, Leon AC, Wisniewski SR, Arnow BA, Markowitz JC, Thase ME. Cognitive behavioral analysis system of psychotherapy and brief supportive psychotherapy for augmentation of antidepressant nonresponse in chronic depression: the REVAMP Trial. Arch Gen Psychiatry. 2009 Nov; 66(11):1178-88.
|
|
|
|
|
19.
|
Gelenberg AJ. Peer review perspective for early career psychiatrists. J Clin Psychiatry. 2009 Nov; 70(11):1599.
|
|
|
|
|
20.
|
Ghuman JK, Aman MG, Lecavalier L, Riddle MA, Gelenberg A, Wright R, Rice S, Ghuman HS, Fort C. Randomized, placebo-controlled, crossover study of methylphenidate for attention-deficit/hyperactivity disorder symptoms in preschoolers with developmental disorders. J Child Adolesc Psychopharmacol. 2009 Aug; 19(4):329-39.
|
|
|
|
|
21.
|
Ghuman JK, Aman MG, Ghuman HS, Reichenbacher T, Gelenberg A, Wright R, Rice S, Fort C. Prospective, naturalistic, pilot study of open-label atomoxetine treatment in preschool children with attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol. 2009 Apr; 19(2):155-66.
|
|
|
|
|
22.
|
Rothschild AJ, Dunlop BW, Dunner DL, Friedman ES, Gelenberg A, Holland P, Kocsis JH, Kornstein SG, Shelton R, Trivedi MH, Zajecka JM, Goldstein C, Thase ME, Pedersen R, Keller MB. Assessing rates and predictors of tachyphylaxis during the prevention of recurrent episodes of depression with venlafaxine ER for two years (PREVENT) study. Psychopharmacol Bull. 2009; 42(3):5-20.
|
|
|
|
|
23.
|
Gelenberg AJ, Freeman MP. JCP's circle of honor and peer reviewers. J Clin Psychiatry. 2009 Jan; 70(1):6-10.
|
|
|
|
|
24.
|
Gelenberg AJ. e-Etiquette. J Clin Psychiatry. 2009 Jan; 70(1):103.
|
|
|
|
|
25.
|
Gelenberg AJ, Thase ME, Meyer RE, Goodwin FK, Katz MM, Kraemer HC, Potter WZ, Shelton RC, Fava M, Khan A, Trivedi MH, Ninan PT, Mann JJ, Bergeson S, Endicott J, Kocsis JH, Leon AC, Manji HK, Rosenbaum JF. The history and current state of antidepressant clinical trial design: a call to action for proof-of-concept studies. J Clin Psychiatry. 2008 Oct; 69(10):1513-28.
|
|
|
|
|
26.
|
Gelenberg AJ. The search for knowledge: developing the American Psychiatric Association's practice guideline for major depressive disorder. J Clin Psychiatry. 2008 Oct; 69(10):1658-9.
|
|
|
|
|
27.
|
Manber R, Kraemer HC, Arnow BA, Trivedi MH, Rush AJ, Thase ME, Rothbaum BO, Klein DN, Kocsis JH, Gelenberg AJ, Keller ME. Faster remission of chronic depression with combined psychotherapy and medication than with each therapy alone. J Consult Clin Psychol. 2008 Jun; 76(3):459-67.
|
|
|
|
|
28.
|
Freeman MP, Davis M, Sinha P, Wisner KL, Hibbeln JR, Gelenberg AJ. Omega-3 fatty acids and supportive psychotherapy for perinatal depression: a randomized placebo-controlled study. J Affect Disord. 2008 Sep; 110(1-2):142-8.
|
|
|
|
|
29.
|
Kocsis JH, Gelenberg AJ, Rothbaum B, Klein DN, Trivedi MH, Manber R, Keller MB, Howland R, Thase ME. Chronic forms of major depression are still undertreated in the 21st century: systematic assessment of 801 patients presenting for treatment. J Affect Disord. 2008 Sep; 110(1-2):55-61.
|
|
|
|
|
30.
|
Gelenberg AJ, de Leon J, Evins AE, Parks JJ, Rigotti NA. Smoking cessation in patients with psychiatric disorders. Prim Care Companion J Clin Psychiatry. 2008; 10(1):52-8.
|
|
|
|
|
31.
|
Trivedi MH, Kocsis JH, Thase ME, Morris DW, Wisniewski SR, Leon AC, Gelenberg AJ, Klein DN, Niederehe G, Schatzberg AF, Ninan PT, Keller MB. REVAMP - Research Evaluating the Value of Augmenting Medication with Psychotherapy: rationale and design. Psychopharmacol Bull. 2008; 41(4):5-33.
|
|
|
|
|
32.
|
Keller MB, Trivedi MH, Thase ME, Shelton RC, Kornstein SG, Nemeroff CB, Friedman ES, Gelenberg AJ, Kocsis JH, Dunner DL, Dunlop BW, Hirschfeld RM, Rothschild AJ, Ferguson JM, Schatzberg AF, Zajecka JM, Pedersen R, Yan B, Ahmed S, Schmidt M, Ninan PT. The Prevention of Recurrent Episodes of Depression with Venlafaxine for Two Years (PREVENT) study: outcomes from the acute and continuation phases. Biol Psychiatry. 2007 Dec 15; 62(12):1371-9.
|
|
|
|
|
33.
|
Gelenberg AJ, de Leon J, Evins AE, Parks JJ, Rigotti NA. Smoking cessation in patients with psychiatric disorders. J Clin Psychiatry. 2007 Sep; 68(9):1404-10.
|
|
|
|
|
34.
|
Keller MB, Trivedi MH, Thase ME, Shelton RC, Kornstein SG, Nemeroff CB, Friedman ES, Gelenberg AJ, Kocsis JH, Dunner DL, Hirschfeld RM, Rothschild AJ, Ferguson JM, Schatzberg AF, Zajecka JM, Pedersen RD, Yan B, Ahmed S, Musgnung J, Ninan PT. The Prevention of Recurrent Episodes of Depression with Venlafaxine for Two Years (PREVENT) Study: Outcomes from the 2-year and combined maintenance phases. J Clin Psychiatry. 2007 Aug; 68(8):1246-56.
|
|
|
|
|
35.
|
Kocsis JH, Thase ME, Trivedi MH, Shelton RC, Kornstein SG, Nemeroff CB, Friedman ES, Gelenberg AJ, Dunner DL, Hirschfeld RM, Rothschild AJ, Ferguson JM, Schatzberg AF, Zajecka JM, Pedersen RD, Yan B, Ahmed S, Musgnung J, Ninan PT, Keller MB. Prevention of recurrent episodes of depression with venlafaxine ER in a 1-year maintenance phase from the PREVENT Study. J Clin Psychiatry. 2007 Jul; 68(7):1014-23.
|
|
|
|
|
36.
|
Williams MM, Clouse RE, Nix BD, Rubin EH, Sayuk GS, McGill JB, Gelenberg AJ, Ciechanowski PS, Hirsch IB, Lustman PJ. Efficacy of sertraline in prevention of depression recurrence in older versus younger adults with diabetes. Diabetes Care. 2007 Apr; 30(4):801-6.
|
|
|
|
|
37.
|
Gelenberg AJ, Hopkins HS. Assessing and treating depression in primary care medicine. Am J Med. 2007 Feb; 120(2):105-8.
|
|
|
|
|
38.
|
Gelenberg AJ, Freeman MP. The art (and blood sport) of psychopharmacology research: who has a dog in the fight? J Clin Psychiatry. 2007 Feb; 68(2):185.
|
|
|
|
|
39.
|
Gelenberg AJ. Staying true to mission. World Psychiatry. 2007 Feb; 6(1):31-2.
|
|
|
|
|
40.
|
Nurnberg HG, Fava M, Gelenberg AJ, Hensley PL, Paine S. Open-label sildenafil treatment of partial and non-responders to double-blind treatment in men with antidepressant-associated sexual dysfunction. Int J Impot Res. 2007 Mar-Apr; 19(2):167-75.
|
|
|
|
|
41.
|
Rush AJ, Kraemer HC, Sackeim HA, Fava M, Trivedi MH, Frank E, Ninan PT, Thase ME, Gelenberg AJ, Kupfer DJ, Regier DA, Rosenbaum JF, Ray O, Schatzberg AF. Report by the ACNP Task Force on response and remission in major depressive disorder. Neuropsychopharmacology. 2006 Sep; 31(9):1841-53.
|
|
|
|
|
42.
|
Lustman PJ, Clouse RE, Nix BD, Freedland KE, Rubin EH, McGill JB, Williams MM, Gelenberg AJ, Ciechanowski PS, Hirsch IB. Sertraline for prevention of depression recurrence in diabetes mellitus: a randomized, double-blind, placebo-controlled trial. Arch Gen Psychiatry. 2006 May; 63(5):521-9.
|
|
|
|
|
43.
|
Gelenberg AJ, Kocsis JH, McCullough JP, Ninan PT, Thase ME. The state of knowledge of chronic depression. J Clin Psychiatry. 2006 Feb; 67(2):179-84.
|
|
|
|
|
44.
|
Freeman MP, Hibbeln JR, Wisner KL, Brumbach BH, Watchman M, Gelenberg AJ. Randomized dose-ranging pilot trial of omega-3 fatty acids for postpartum depression. Acta Psychiatr Scand. 2006 Jan; 113(1):31-5.
|
|
|
|
|
45.
|
Gelenberg AJ, Kocsis JH, McCullough JP, Ninan PT, Thase ME. The state of knowledge of chronic depression. Prim Care Companion J Clin Psychiatry. 2006; 8(2):60-5.
|
|
|
|
|
46.
|
Freeman MP, Gelenberg AJ. Bipolar disorder in women: reproductive events and treatment considerations. Acta Psychiatr Scand. 2005 Aug; 112(2):88-96.
|
|
|
|
|
47.
|
Gelenberg AJ. Funding, conflicts, and paradigms. J Clin Psychiatry. 2005 May; 66(5):554.
|
|
|
|
|
48.
|
Rush AJ, Trivedi MH, Carmody TJ, Ibrahim HM, Markowitz JC, Keitner GI, Kornstein SG, Arnow B, Klein DN, Manber R, Dunner DL, Gelenberg AJ, Kocsis JH, Nemeroff CB, Fawcett J, Thase ME, Russell JM, Jody DN, Borian FE, Keller MB. Self-reported depressive symptom measures: sensitivity to detecting change in a randomized, controlled trial of chronically depressed, nonpsychotic outpatients. Neuropsychopharmacology. 2005 Feb; 30(2):405-16.
|
|
|
|
|
49.
|
Liebowitz MR, Gelenberg AJ, Munjack D. Venlafaxine extended release vs placebo and paroxetine in social anxiety disorder. Arch Gen Psychiatry. 2005 Feb; 62(2):190-8.
|
|
|
|
|
50.
|
Kumet R, Gelenberg AJ. The effectiveness of generic agents in psychopharmacologic treatment. Essent Psychopharmacol. 2005; 6(2):104-11.
|
|
|
|
|
51.
|
Gelenberg AJ. Reliability and risks of generic psychopharmacologic agents. Essent Psychopharmacol. 2005; 6(6):348-55.
|
|
|
|
|
52.
|
Kane JM, Barrett EJ, Casey DE, Correll CU, Gelenberg AJ, Klein S, Newcomer JW. Metabolic effects of treatment with atypical antipsychotics. J Clin Psychiatry. 2004 Nov; 65(11):1447-55.
|
|
|
|
|
53.
|
Gelenberg AJ, Shelton RC, Crits-Christoph P, Keller MB, Dunner DL, Hirschfeld RM, Thase ME, Russell JM, Lydiard RB, Gallop RJ, Todd L, Hellerstein DJ, Goodnick PJ, Keitner GI, Stahl SM, Halbreich U, Hopkins HS. The effectiveness of St. John's Wort in major depressive disorder: a naturalistic phase 2 follow-up in which nonresponders were provided alternate medication. J Clin Psychiatry. 2004 Aug; 65(8):1114-9.
|
|
|
|
|
54.
|
Gelenberg AJ. Honoring our evidence base. J Clin Psychiatry. 2004 Jun; 65(6):750-1.
|
|
|
|
|
55.
|
Badger T, Gelenberg AJ, Berren M. Consultative intervention to improve outcomes of high utilizers in a public mental health system. Perspect Psychiatr Care. 2004 Apr-Jun; 40(2):53-60, 69.
|
|
|
|
|
56.
|
Delate T, Gelenberg AJ, Simmons VA, Motheral BR. Trends in the use of antidepressants in a national sample of commercially insured pediatric patients, 1998 to 2002. Psychiatr Serv. 2004 Apr; 55(4):387-91.
|
|
|
|
|
57.
|
Gelenberg AJ, Trivedi MH, Rush AJ, Thase ME, Howland R, Klein DN, Kornstein SG, Dunner DL, Markowitz JC, Hirschfeld RM, Keitner GI, Zajecka J, Kocsis JH, Russell JM, Miller I, Manber R, Arnow B, Rothbaum B, Munsaka M, Banks P, Borian FE, Keller MB. Randomized, placebo-controlled trial of nefazodone maintenance treatment in preventing recurrence in chronic depression. Biol Psychiatry. 2003 Oct 15; 54(8):806-17.
|
|
|
|
|
58.
|
Gelenberg AJ, Pies R. Matching the bipolar patient and the mood stabilizer. Ann Clin Psychiatry. 2003 Sep-Dec; 15(3-4):203-16.
|
|
|
|
|
59.
|
Gnanadesikan M, Freeman MP, Gelenberg AJ. Alternatives to lithium and divalproex in the maintenance treatment of bipolar disorder. Bipolar Disord. 2003 Jun; 5(3):203-16.
|
|
|
|
|
60.
|
Nurnberg HG, Hensley PL, Gelenberg AJ, Fava M, Lauriello J, Paine S. Treatment of antidepressant-associated sexual dysfunction with sildenafil: a randomized controlled trial. JAMA. 2003 Jan 1; 289(1):56-64.
|
|
|
|
|
61.
|
Baker RW, Milton DR, Stauffer VL, Gelenberg A, Tohen M. Placebo-controlled trials do not find association of olanzapine with exacerbation of bipolar mania. J Affect Disord. 2003 Jan; 73(1-2):147-53.
|
|
|
|
|
62.
|
Badger TA, McNiece C, Bonham E, Jacobson J, Gelenberg AJ. Health outcomes for people with serious mental illness: a case study. Perspect Psychiatr Care. 2003 Jan-Mar; 39(1):23-32.
|
|
|
|
|
63.
|
Nurnberg HG, Seidman SN, Gelenberg AJ, Fava M, Rosen R, Shabsigh R. Depression, antidepressant therapies, and erectile dysfunction: clinical trials of sildenafil citrate (Viagra) in treated and untreated patients with depression. Urology. 2002 Sep; 60(2 Suppl 2):58-66.
|
|
|
|
|
64.
|
Zajecka J, Dunner DL, Gelenberg AJ, Hirschfeld RM, Kornstein SG, Ninan PT, Rush AJ, Thase ME, Trivedi MH, Arnow BA, Borian FE, Manber R, Keller MB. Sexual function and satisfaction in the treatment of chronic major depression with nefazodone, psychotherapy, and their combination. J Clin Psychiatry. 2002 Aug; 63(8):709-16.
|
|
|
|
|
65.
|
Thase ME, Rush AJ, Howland RH, Kornstein SG, Kocsis JH, Gelenberg AJ, Schatzberg AF, Koran LM, Keller MB, Russell JM, Hirschfeld RM, LaVange LM, Klein DN, Fawcett J, Harrison W. Double-blind switch study of imipramine or sertraline treatment of antidepressant-resistant chronic depression. Arch Gen Psychiatry. 2002 Mar; 59(3):233-9.
|
|
|
|
|
66.
|
Gelenberg AJ. Out of the box. Arch Gen Psychiatry. 2002 Mar; 59(3):281.
|
|
|
|
|
67.
|
Delgado PL, Moreno FA, Onate L, Gelenberg AJ. Sequential catecholamine and serotonin depletion in mirtazapine-treated depressed patients. Int J Neuropsychopharmacol. 2002 Mar; 5(1):63-6.
|
|
|
|
|
68.
|
Kupfer DJ, Chengappa KN, Gelenberg AJ, Hirschfeld RM, Goldberg JF, Sachs GS, Grochocinski VJ, Houck PR, Kolar AB. Citalopram as adjunctive therapy in bipolar depression. J Clin Psychiatry. 2001 Dec; 62(12):985-90.
|
|
|
|
|
69.
|
Bauer MS, Williford WO, Dawson EE, Akiskal HS, Altshuler L, Fye C, Gelenberg A, Glick H, Kinosian B, Sajatovic M. Principles of effectiveness trials and their implementation in VA Cooperative Study #430: 'Reducing the efficacy-effectiveness gap in bipolar disorder'. J Affect Disord. 2001 Dec; 67(1-3):61-78.
|
|
|
|
|
70.
|
Nurnberg HG, Gelenberg A, Hargreave TB, Harrison WM, Siegel RL, Smith MD. Efficacy of sildenafil citrate for the treatment of erectile dysfunction in men taking serotonin reuptake inhibitors. Am J Psychiatry. 2001 Nov; 158(11):1926-8.
|
|
|
|
|
71.
|
Gelenberg AJ. Can lithium help to prevent suicide? Acta Psychiatr Scand. 2001 Sep; 104(3):161-2.
|
|
|
|
|
72.
|
Koran LM, Gelenberg AJ, Kornstein SG, Howland RH, Friedman RA, DeBattista C, Klein D, Kocsis JH, Schatzberg AF, Thase ME, Rush AJ, Hirschfeld RM, LaVange LM, Keller MB. Sertraline versus imipramine to prevent relapse in chronic depression. J Affect Disord. 2001 Jun; 65(1):27-36.
|
|
|
|
|
73.
|
Shelton RC, Keller MB, Gelenberg A, Dunner DL, Hirschfeld R, Thase ME, Russell J, Lydiard RB, Crits-Cristoph P, Gallop R, Todd L, Hellerstein D, Goodnick P, Keitner G, Stahl SM, Halbreich U. Effectiveness of St John's wort in major depression: a randomized controlled trial. JAMA. 2001 Apr 18; 285(15):1978-86.
|
|
|
|
|
74.
|
Wisner KL, Zarin DA, Holmboe ES, Appelbaum PS, Gelenberg AJ, Leonard HL, Frank E. Risk-benefit decision making for treatment of depression during pregnancy. Am J Psychiatry. 2000 Dec; 157(12):1933-40.
|
|
|
|
|
75.
|
Gelenberg AJ, Chesen CL. How fast are antidepressants? J Clin Psychiatry. 2000 Oct; 61(10):712-21.
|
|
|
|
|
76.
|
Kornstein SG, Schatzberg AF, Thase ME, Yonkers KA, McCullough JP, Keitner GI, Gelenberg AJ, Ryan CE, Hess AL, Harrison W, Davis SM, Keller MB. Gender differences in chronic major and double depression. J Affect Disord. 2000 Oct; 60(1):1-11.
|
|
|
|
|
77.
|
Kornstein SG, Schatzberg AF, Thase ME, Yonkers KA, McCullough JP, Keitner GI, Gelenberg AJ, Davis SM, Harrison WM, Keller MB. Gender differences in treatment response to sertraline versus imipramine in chronic depression. Am J Psychiatry. 2000 Sep; 157(9):1445-52.
|
|
|
|
|
78.
|
Hopkins HS, Gelenberg AJ. Serum lithium levels and the outcome of maintenance therapy of bipolar disorder. Bipolar Disord. 2000 Sep; 2(3 Pt 1):174-9.
|
|
|
|
|
79.
|
Gelenberg AJ, Lydiard RB, Rudolph RL, Aguiar L, Haskins JT, Salinas E. Efficacy of venlafaxine extended-release capsules in nondepressed outpatients with generalized anxiety disorder: A 6-month randomized controlled trial. JAMA. 2000 Jun 21; 283(23):3082-8.
|
|
|
|
|
80.
|
Gelenberg AJ, Delgado P, Nurnberg HG. Sexual side effects of antidepressant drugs. Curr Psychiatry Rep. 2000 Jun; 2(3):223-7.
|
|
|
|
|
81.
|
Berndt ER, Koran LM, Finkelstein SN, Gelenberg AJ, Kornstein SG, Miller IM, Thase ME, Trapp GA, Keller MB. Lost human capital from early-onset chronic depression. Am J Psychiatry. 2000 Jun; 157(6):940-7.
|
|
|
|
|
82.
|
Keller MB, McCullough JP, Klein DN, Arnow B, Dunner DL, Gelenberg AJ, Markowitz JC, Nemeroff CB, Russell JM, Thase ME, Trivedi MH, Zajecka J. A comparison of nefazodone, the cognitive behavioral-analysis system of psychotherapy, and their combination for the treatment of chronic depression. N Engl J Med. 2000 May 18; 342(20):1462-70.
|
|
|
|
|
83.
|
Gelenberg AJ, McGahuey C, Laukes C, Okayli G, Moreno F, Zentner L, Delgado P. Mirtazapine substitution in SSRI-induced sexual dysfunction. J Clin Psychiatry. 2000 May; 61(5):356-60.
|
|
|
|
|
84.
|
McGahuey CA, Gelenberg AJ, Laukes CA, Moreno FA, Delgado PL, McKnight KM, Manber R. The Arizona Sexual Experience Scale (ASEX): reliability and validity. J Sex Marital Ther. 2000 Jan-Mar; 26(1):25-40.
|
|
|
|
|
85.
|
Wisner KL, Gelenberg AJ, Leonard H, Zarin D, Frank E. Pharmacologic treatment of depression during pregnancy. JAMA. 1999 Oct 6; 282(13):1264-9.
|
|
|
|
|
86.
|
Moreno FA, Gelenberg AJ, Heninger GR, Potter RL, McKnight KM, Allen J, Phillips AP, Delgado PL. Tryptophan depletion and depressive vulnerability. Biol Psychiatry. 1999 Aug 15; 46(4):498-505.
|
|
|
|
|
87.
|
Gelenberg A. Depression is still underrecognized and undertreated. Arch Intern Med. 1999 Aug 9-23; 159(15):1657-8.
|
|
|
|
|
88.
|
Bartlik B, Kocsis JH, Legere R, Villaluz J, Kossoy A, Gelenberg AJ. Sexual dysfunction secondary to depressive disorders. J Gend Specif Med. 1999 Mar-Apr; 2(2):52-60.
|
|
|
|
|
89.
|
Keller MB, Kocsis JH, Thase ME, Gelenberg AJ, Rush AJ, Koran L, Schatzberg A, Russell J, Hirschfeld R, Klein D, McCullough JP, Fawcett JA, Kornstein S, LaVange L, Harrison W. Maintenance phase efficacy of sertraline for chronic depression: a randomized controlled trial. JAMA. 1998 Nov 18; 280(19):1665-72.
|
|
|
|
|
90.
|
Rush AJ, Koran LM, Keller MB, Markowitz JC, Harrison WM, Miceli RJ, Fawcett JA, Gelenberg AJ, Hirschfeld RM, Klein DN, Kocsis JH, McCullough JP, Schatzberg AF, Thase ME. The treatment of chronic depression, part 1: study design and rationale for evaluating the comparative efficacy of sertraline and imipramine as acute, crossover, continuation, and maintenance phase therapies. J Clin Psychiatry. 1998 Nov; 59(11):589-97.
|
|
|
|
|
91.
|
Keller MB, Gelenberg AJ, Hirschfeld RM, Rush AJ, Thase ME, Kocsis JH, Markowitz JC, Fawcett JA, Koran LM, Klein DN, Russell JM, Kornstein SG, McCullough JP, Davis SM, Harrison WM. The treatment of chronic depression, part 2: a double-blind, randomized trial of sertraline and imipramine. J Clin Psychiatry. 1998 Nov; 59(11):598-607.
|
|
|
|
|
92.
|
Gelenberg AJ. Knowing our limits. Acta Psychiatr Scand. 1998 Oct; 98(4):261.
|
|
|
|
|
93.
|
Moreno FA, Gelenberg AJ, Bachar K, Delgado PL. Pindolol augmentation of treatment-resistant depressed patients. J Clin Psychiatry. 1997 Oct; 58(10):437-9.
|
|
|
|
|
94.
|
Solomon DA, Ristow WR, Keller MB, Kane JM, Gelenberg AJ, Rosenbaum JF, Warshaw MG. Serum lithium levels and psychosocial function in patients with bipolar I disorder. Am J Psychiatry. 1996 Oct; 153(10):1301-7.
|
|
|
|
|
95.
|
Delgado PL, Gelenberg AJ, Moreno F, Laukes C, Strayer L. Tryptophan and 5-HT in psychiatric illness. Adv Exp Med Biol. 1996; 398:73.
|
|
|
|
|
96.
|
Gelenberg AJ, Hopkins HS. Antipsychotics in bipolar disorder. J Clin Psychiatry. 1996; 57 Suppl 9:49-52.
|
|
|
|
|
97.
|
Gelenberg AJ. Threats and promises. J Clin Psychiatry. 1995 Oct; 56(10):448-9.
|
|
|
|
|
98.
|
Gelenberg AJ, Jefferson JW. Lithium tremor. J Clin Psychiatry. 1995 Jul; 56(7):283-7.
|
|
|
|
|
99.
|
Hopkins HS, Gelenberg AJ. Fluoxetine and sexual dysfunction. JAMA. 1995 May 17; 273(19):1489-90.
|
|
|
|
|
100.
|
Gelenberg AJ, Ottosson JO. Editorial statement. Acta Psychiatr Scand. 1995 Mar; 91(3):145.
|
|
|
|
|
101.
|
Keller MB, Harrison W, Fawcett JA, Gelenberg A, Hirschfeld RM, Klein D, Kocsis JH, McCullough JP, Rush AJ, Schatzberg A, et al. Treatment of chronic depression with sertraline or imipramine: preliminary blinded response rates and high rates of undertreatment in the community. Psychopharmacol Bull. 1995; 31(2):205-12.
|
|
|
|
|
102.
|
Gelenberg AJ. Major complications of neuroleptic drug use. West J Med. 1994 Jan; 160(1):55-6.
|
|
|
|
|
103.
|
Hopkins HS, Gelenberg AJ. Treatment of bipolar disorder: how far have we come? Psychopharmacol Bull. 1994; 30(1):27-38.
|
|
|
|
|
104.
|
Gelenberg AJ. Psychiatry 2013. J Clin Psychiatry. 1993 Aug; 54(8):287-8.
|
|
|
|
|
105.
|
Gelenberg AJ. Postmarketing surveillance: perspectives of a journal editor. Psychopharmacol Bull. 1993; 29(1):135-7.
|
|
|
|
|
106.
|
Gelenberg AJ, Hopkins HS. Report on efficacy of treatments for bipolar disorder. Psychopharmacol Bull. 1993; 29(4):447-56.
|
|
|
|
|
107.
|
Delgado PL, Miller HL, Salomon RM, Licinio J, Heninger GR, Gelenberg AJ, Charney DS. Monoamines and the mechanism of antidepressant action: effects of catecholamine depletion on mood of patients treated with antidepressants. Psychopharmacol Bull. 1993; 29(3):389-96.
|
|
|
|
|
108.
|
Gelenberg AJ. If not now, when? J Clin Psychiatry. 1992 Aug; 53(8):266.
|
|
|
|
|
109.
|
Keller MB, Lavori PW, Kane JM, Gelenberg AJ, Rosenbaum JF, Walzer EA, Baker LA. Subsyndromal symptoms in bipolar disorder. A comparison of standard and low serum levels of lithium. Arch Gen Psychiatry. 1992 May; 49(5):371-6.
|
|
|
|
|
110.
|
Gelenberg AJ. Imperfect drugs in an imperfect world. J Clin Psychiatry. 1992 Feb; 53(2):39-40.
|
|
|
|
|
111.
|
Spring B, Gelenberg AJ, Garvin R, Thompson S. Amitriptyline, clovoxamine and cognitive function: a placebo-controlled comparison in depressed outpatients. Psychopharmacology (Berl). 1992; 108(3):327-32.
|
|
|
|
|
112.
|
Wojcik JD, Falk WE, Fink JS, Cole JO, Gelenberg AJ. A review of 32 cases of tardive dystonia. Am J Psychiatry. 1991 Aug; 148(8):1055-9.
|
|
|
|
|
113.
|
Gelenberg AJ. Psychiatry in the 1990s. J Clin Psychiatry. 1991 May; 52(5):205-7.
|
|
|
|
|
114.
|
Gelenberg AJ. Depression, depressants, and antidepressants. Arch Intern Med. 1990 Nov; 150(11):2245.
|
|
|
|
|
115.
|
Gelenberg AJ, Wojcik JD, Falk WE, Spring B, Brotman AW, Galvin-Nadeau M. Clovoxamine in the treatment of depressed outpatients: a double-blind, parallel-group comparison against amitriptyline and placebo. Compr Psychiatry. 1990 Jul-Aug; 31(4):307-14.
|
|
|
|
|
116.
|
Gelenberg AJ, Wojcik JD, Falk WE, Baldessarini RJ, Zeisel SH, Schoenfeld D, Mok GS. Tyrosine for depression: a double-blind trial. J Affect Disord. 1990 Jun; 19(2):125-32.
|
|
|
|
|
117.
|
Gelenberg AJ, Dorer DJ, Wojcik JD, Falk WE, Brotman AW, Leahy L. A crossover study of lecithin treatment of tardive dyskinesia. J Clin Psychiatry. 1990 Apr; 51(4):149-53.
|
|
|
|
|
118.
|
Wilson SN, Surman OS, Colvin R, Ozonoff D, Gelenberg AJ, Jenike MA, Manschreck T, Pato C. Unusual lymphocyte subset distribution in some depressed patients. J Clin Psychiatry. 1990 Feb; 51(2):51-2.
|
|
|
|
|
119.
|
Gelenberg AJ, Carroll JA, Baudhuin MG, Jefferson JW, Greist JH. The meaning of serum lithium levels in maintenance therapy of mood disorders: a review of the literature. J Clin Psychiatry. 1989 Dec; 50 Suppl:17-22; discussion 45-7.
|
|
|
|
|
120.
|
Gelenberg AJ, Kane JM, Keller MB, Lavori P, Rosenbaum JF, Cole K, Lavelle J. Comparison of standard and low serum levels of lithium for maintenance treatment of bipolar disorder. N Engl J Med. 1989 Nov 30; 321(22):1489-93.
|
|
|
|
|
121.
|
Rosebush PI, Stewart TD, Gelenberg AJ. Twenty neuroleptic rechallenges after neuroleptic malignant syndrome in 15 patients. J Clin Psychiatry. 1989 Aug; 50(8):295-8.
|
|
|
|
|
122.
|
Prien RF, Gelenberg AJ. Alternatives to lithium for preventive treatment of bipolar disorder. Am J Psychiatry. 1989 Jul; 146(7):840-8.
|
|
|
|
|
123.
|
Gelenberg AJ, Van Putten T, Lavori PW, Wojcik JD, Falk WE, Marder S, Galvin-Nadeau M, Spring B, Mohs RC, Brotman AW. Anticholinergic effects on memory: benztropine versus amantadine. J Clin Psychopharmacol. 1989 Jun; 9(3):180-5.
|
|
|
|
|
124.
|
Gelenberg AJ, Bellinghausen B, Wojcik JD, Falk WE, Farhadi AM. Patients with neuroleptic malignant syndrome histories: what happens when they are rehospitalized? J Clin Psychiatry. 1989 May; 50(5):178-80.
|
|
|
|
|
125.
|
Sachs GS, Gelenberg AJ, Bellinghausen B, Wojcik J, Falk WE, Farhadi AM, Jenike M. Ergoloid mesylates and ECT. J Clin Psychiatry. 1989 Mar; 50(3):87-90.
|
|
|
|
|
126.
|
Wolfe N, Gelenberg AJ, Lydiard RB. Alpha 2-adrenergic receptor sensitivity in depressed patients: relation between 3H-yohimbine binding to platelet membranes and clonidine-induced hypotension. Biol Psychiatry. 1989 Feb 15; 25(4):382-92.
|
|
|
|
|
127.
|
Gelenberg AJ, Wojcik J, Falk WE, Bellinghausen B, Joseph AB. CDP-choline for the treatment of tardive dyskinesia: a small negative series. Compr Psychiatry. 1989 Jan-Feb; 30(1):1-4.
|
|
|
|
|
128.
|
Gelenberg AJ. Lithium efficacy and adverse effects. J Clin Psychiatry. 1988 Nov; 49 Suppl:8-11.
|
|
|
|
|
129.
|
Falk WE, Wojick JD, Gelenberg AJ. Diltiazem for tardive dyskinesia and tardive dystonia. Lancet. 1988 Apr 9; 1(8589):824-5.
|
|
|
|
|
130.
|
Brotman AW, Witkie SM, Gelenberg AJ, Falk WE, Wojcik J, Leahy L. An open trial of maprotiline for the treatment of cocaine abuse: a pilot study. J Clin Psychopharmacol. 1988 Apr; 8(2):125-7.
|
|
|
|
|
131.
|
Gelenberg AJ, Bellinghausen B, Wojcik JD, Falk WE, Sachs GS. A prospective survey of neuroleptic malignant syndrome in a short-term psychiatric hospital. Am J Psychiatry. 1988 Apr; 145(4):517-8.
|
|
|
|
|
132.
|
Brotman AW, Falk WE, Gelenberg AJ. Pharmacologic treatment of depressive subtypes. Psychiatr Med. 1988; 6(3):92-113.
|
|
|
|
|
133.
|
Gelenberg AJ. Significant greater loss of medication from the injection site when fluphenazine (Prolixin) decanoate was injected intramuscularly as contrasted with subcutaneously. J Clin Psychiatry. 1987 Oct; 48(10):425.
|
|
|
|
|
134.
|
Gelenberg AJ. Treating extrapyramidal reactions: some current issues. J Clin Psychiatry. 1987 Sep; 48 Suppl:24-7.
|
|
|
|
|
135.
|
Wolfe N, Cohen BM, Gelenberg AJ. Alpha 2-adrenergic receptors in platelet membranes of depressed patients: increased affinity for 3H-yohimbine. Psychiatry Res. 1987 Feb; 20(2):107-16.
|
|
|
|
|
136.
|
Gelenberg AJ, Wojcik JD, Falk WE, Coggins CH, Brotman AW, Rosenbaum JF, LaBrie RA, Kerman BJ. Effects of lithium on the kidney. Acta Psychiatr Scand. 1987 Jan; 75(1):29-34.
|
|
|
|
|
137.
|
Van Putten T, Gelenberg AJ, Lavori PW, Falk WE, Marder SR, Spring B, Mohs RC, Brotman AW. Anticholinergic effects on memory: benztropine vs. amantadine. Psychopharmacol Bull. 1987; 23(1):26-9.
|
|
|
|
|
138.
|
Sachs GS, Pollack MH, Brotman AW, Farhadi AM, Gelenberg AJ. Enhancement of ECT benefit by yohimbine. J Clin Psychiatry. 1986 Oct; 47(10):508-10.
|
|
|
|
|
139.
|
Brotman AW, Farhadi AM, Gelenberg AJ. Verapamil treatment of acute mania. J Clin Psychiatry. 1986 Mar; 47(3):136-8.
|
|
|
|
|
140.
|
Gelenberg AJ. Pregnancy, psychotropic drugs, and psychiatric disorders. Psychosomatics. 1986 Mar; 27(3):216-7.
|
|
|
|
|
141.
|
Mills MJ, Norquist GS, Shelton RC, Gelenberg AJ, Van Putten T. Consent and liability with neuroleptics: the problem of tardive dyskinesia. Int J Law Psychiatry. 1986; 8(2):243-52.
|
|
|
|
|
142.
|
Gelenberg AJ. Conclusion on convulsions. Psychosomatics. 1985 Dec; 26(12):949.
|
|
|
|
|
143.
|
Falk WE, Gelenberg AJ, Wojcik JD. Amoxapine for the treatment of psychotically depressed subjects. A pilot study. J Nerv Ment Dis. 1985 Feb; 173(2):90-3.
|
|
|
|
|
144.
|
Gelenberg AJ, Wojcik JD, Newell C, Lamping DL, Spring B. A double-blind comparison of clovoxamine and amitriptyline in the treatment of depressed outpatients. J Clin Psychopharmacol. 1985 Feb; 5(1):30-4.
|
|
|
|
|
145.
|
Carr DB, Wool C, Lydiard RB, Fisher J, Gelenberg A, Klerman G. Rate-sensitive inhibition of ACTH release in depression. Am J Psychiatry. 1984 Apr; 141(4):590-2.
|
|
|
|
|
146.
|
Gelenberg AJ, Wojcik JD, Lydiard RB, McCormick MG, Falk WE, Hicks RH, Curren FC, Cohen BM. Double-blind comparison of amoxapine and imipramine in the treatment of depressed patients. J Clin Psychiatry. 1984 Feb; 45(2):54-56, 57-9.
|
|
|
|
|
147.
|
Gelenberg AJ. Use and abuse of anticholinergic drugs in psychiatry. Hillside J Clin Psychiatry. 1984; 6(2):148-55.
|
|
|
|
|
148.
|
Lamping DL, Spring B, Gelenberg AJ. Effects of two antidepressants on memory performance in depressed outpatients: a double-blind study. Psychopharmacology (Berl). 1984; 84(2):254-61.
|
|
|
|
|
149.
|
Gelenberg AJ, Gibson CJ. Tyrosine for the treatment of depression. Nutr Health. 1984; 3(3):163-73.
|
|
|
|
|
150.
|
Gelenberg AJ. New antidepressant drugs: a clinical perspective. Psychopharmacol Bull. 1984; 20(2):291-4.
|
|
|
|
|
151.
|
Gelenberg AJ. General principles of treatment of extrapyramidal syndromes. Clin Neuropharmacol. 1983; 6 Suppl 1:S52-6.
|
|
|
|
|
152.
|
Donaldson SR, Gelenberg AJ, Baldessarini RJ. The pharmacologic treatment of schizophrenia: a progress report. Schizophr Bull. 1983; 9(4):504-27.
|
|
|
|
|
153.
|
Mandel MR, Severe JB, Schooler NR, Gelenberg AJ, Mieske M. Development and prediction of postpsychotic depression in neuroleptic-treated schizophrenics. Arch Gen Psychiatry. 1982 Feb; 39(2):197-203.
|
|
|
|
|
154.
|
Gelenberg AJ, Gibson CJ, Wojcik JD. Neurotransmitter precursors for the treatment of depression. Psychopharmacol Bull. 1982 Jan; 18(1):7-18.
|
|
|
|
|
155.
|
Gelenberg AJ, Wojcik JD, Gibson CJ, Wurtman RJ. Tyrosine for depression. J Psychiatr Res. 1982-1983; 17(2):175-80.
|
|
|
|
|
156.
|
Lydiard RB, Gelenberg AJ. Hazards and adverse effects of lithium. Annu Rev Med. 1982; 33:327-44.
|
|
|
|
|
157.
|
Lydiard RB, Gelenberg AJ. Amoxapine--an antidepressant with some neuroleptic properties? A review of its chemistry, animal pharmacology and toxicology, human pharmacology, and clinical efficacy. Pharmacotherapy. 1981 Nov-Dec; 1(3):163-78.
|
|
|
|
|
158.
|
Gelenberg AJ, Wojcik JD, Coggins CH, Rosenbaum JF, LaBrie RA. Renal function monitoring in patients receiving lithium carbonate. J Clin Psychiatry. 1981 Nov; 42(11):428-31.
|
|
|
|
|
159.
|
Wells BG, Gelenberg AJ. Chemistry, pharmacology, pharmacokinetics, adverse effects, and efficacy of the antidepressant maprotiline hydrochloride. Pharmacotherapy. 1981 Sep-Oct; 1(2):121-39.
|
|
|
|
|
160.
|
Cooper DS, Gelenberg AJ, Wojcik JC, Saxe VC, Ridgway EC, Maloof F. The effect of amoxapine and imipramine on serum prolactin levels. Arch Intern Med. 1981 Jul; 141(8):1023-5.
|
|
|
|
|
161.
|
Shale JH, Gelenberg AJ. The amobarbital interview. Mil Med. 1980 Dec; 145(12):825-8.
|
|
|
|
|
162.
|
Gelenberg AJ. Tardive dyskinesia and lithium-associated nephropathy: are you liable? J Clin Psychiatry. 1980 Nov; 41(11):368-9.
|
|
|
|
|
163.
|
Gelenberg AJ, Wurtman RJ. L-tyrosine in depression. Lancet. 1980 Oct 18; 2(8199):863-4.
|
|
|
|
|
164.
|
Gelenberg AJ. Nutrition in psychiatry: we are what we eat? J Clin Psychiatry. 1980 Oct; 41(10):328-9.
|
|
|
|
|
165.
|
Wojcik JD, Gelenberg AJ, LaBrie RA, Mieske M. Prevalence of tardive dyskinesia in an outpatient population. Compr Psychiatry. 1980 Sep-Oct; 21(5):370-80.
|
|
|
|
|
166.
|
Gelenberg AJ, Wojcik JD, Growdon JH, Sved AF, Wurtman RJ. Tyrosine for the treatment of depression. Am J Psychiatry. 1980 May; 137(5):622-3.
|
|
|
|
|
167.
|
Zeisel SH, Gelenberg AJ, Growdon JH, Wurtman RJ. Use of choline and lecithin in the treatment of tardive dyskinesia. Adv Biochem Psychopharmacol. 1980; 24:463-70.
|
|
|
|
|
168.
|
Levine J, Schooler NR, Severe J, Escobar J, Gelenberg A, Mandel M, Sovner R, Steinbook R. Discontinuation of oral and depot fluphenazine in schizophrenic patients after one year of continuous medication: a controlled study. Adv Biochem Psychopharmacol. 1980; 24:483-93.
|
|
|
|
|
169.
|
Baldessarini RJ, Gelenberg AJ. Using physostigmine safely. Am J Psychiatry. 1979 Dec; 136(12):1608-9.
|
|
|
|
|
170.
|
Gelenberg AJ, Cooper DS, Doller JC, Maloof F. Galactorrhea and hyperprolactinemia associated with amoxapine therapy. Report of a case. JAMA. 1979 Oct 26; 242(17):1900-1.
|
|
|
|
|
171.
|
Gelenberg AJ. Single case study. Amoxapine, a new antidepressant, appears in human milk. J Nerv Ment Dis. 1979 Oct; 167(10):635-6.
|
|
|
|
|
172.
|
Gelenberg AJ. Psychotherapy in severe depression: hypothesis-generating versus hypothesis-testing. J Clin Psychiatry. 1979 Jul; 40(7):285-6.
|
|
|
|
|
173.
|
Gelenberg AJ. Antidepressants in the general hospital. Can Med Assoc J. 1979 Jun 9; 120(11):1377-85.
|
|
|
|
|
174.
|
Gelenberg AJ, Doller-Wojcik JC, Growdon JH. Choline and lecithin in the treatment of tardive dyskinesia: preliminary results from a pilot study. Am J Psychiatry. 1979 Jun; 136(6):772-6.
|
|
|
|
|
175.
|
Gelenberg AJ, Doller JC. Clozapine versus chlorpromazine for the treatment of schizophrenia: preliminary results from a double-blind study. J Clin Psychiatry. 1979 May; 40(5):238-40.
|
|
|
|
|
176.
|
Gelenberg AJ. Choline and lecithin for the treatment of tardive dyskinesia [proceedings]. Psychopharmacol Bull. 1979 Apr; 15(2):74-5.
|
|
|
|
|
177.
|
Feighner JP, Brauzer B, Gelenberg AJ, Gomez E, Kiev A, Kurland ML, Weiss BL. A placebo-controlled multicenter trial of Limbitrol versus its components (amitriptyline and chlordiazepoxide) in the symptomatic treatment of depressive illness. Psychopharmacology (Berl). 1979 Mar 22; 61(2):217-25.
|
|
|
|
|
178.
|
Gelenberg AJ, Doller JC, Schooler NR, Mieske M, Severe J, Mandel MR. Acute extrapyramidal reactions with fluphenazine hydrochloride and fluphenazine decanoate. Am J Psychiatry. 1979 Feb; 136(2):217-9.
|
|
|
|
|
179.
|
Gelenberg AJ. Treating the outpatient schizophrenic. Postgrad Med. 1978 Nov; 64(5):48-56.
|
|
|
|
|
180.
|
Gelenberg AJ, Klerman GL, Hartmann EL, Salt P. Recurrent unipolar depressions with a 48-hour cycle: report of a case. Br J Psychiatry. 1978 Aug; 133:123-9.
|
|
|
|
|
181.
|
Growdon JH, Gelenberg AJ, Doller J, Hirsch MJ, Wurtman RJ. Lecithin can suppress tardive dyskinesia. N Engl J Med. 1978 May 4; 298(18):1029-30.
|
|
|
|
|
182.
|
Gelenberg AJ, Klerman GL. The effects of amitriptyline and lithium on a patient with 48-hour recurrent depressions. J Nerv Ment Dis. 1978 May; 166(5):365-8.
|
|
|
|
|
183.
|
Gelenberg AJ, Klerman GL. Antidepressants: their use in clinical practice. Ration Drug Ther. 1978 Apr; 12(4):1-7.
|
|
|
|
|
184.
|
Growdon JH, Gelenberg AJ. Choline and lecithin administration to patients with tardive dyskinesia. Trans Am Neurol Assoc. 1978; 103:95-9.
|
|
|
|
|
185.
|
Gelenberg AJ. Cardiac arrhythmias after psychotropic drugs. Am J Cardiol. 1977 Aug; 40(2):297.
|
|
|
|
|
186.
|
Gelenberg AJ, Mandel MR. Catatonic reactions to high-potency neuroleptic drugs. Arch Gen Psychiatry. 1977 Aug; 34(8):947-50.
|
|
|
|
|
187.
|
Gelenberg AJ. Munchausen's syndrome with a psychiatric presentation. Dis Nerv Syst. 1977 May; 38(5):378-80.
|
|
|
|
|
188.
|
Gelenberg AJ. Criteria for the diagnosis of catatonia. Am J Psychiatry. 1977 Apr; 134(4):462-3.
|
|
|
|
|
189.
|
Gelenberg AJ. The catatonic syndrome. Lancet. 1976 Jun 19; 1(7973):1339-41.
|
|
|
|
|
190.
|
Gelenberg AJ. Computerized tomography in patients with tardive dyskinesia. Am J Psychiatry. 1976 May; 133(5):578-9.
|
|
|
|
|
191.
|
Baldessarini RJ, Gelenberg AJ, Lipinski JF. Letter: Grams of antipsychotics? N Engl J Med. 1976 Jan 8; 294(2):113-4.
|
|
|
|
|
192.
|
Gelenberg AJ, Poskanzer DC. The effect of dantrolene sodium on spasticity in multiple sclerosis. Neurology. 1973 Dec; 23(12):1313-5.
|
|
|
|
|
193.
|
Gelenberg AJ. Psychiatry as a medical specialty. Am J Psychiatry. 1972 Nov; 129(5):633-4.
|
|
|
|